About RoC Skincare, founded in Paris in 1957

French pharmacy and dermatology have shaped RoC Skincare since its founding.

Explore RoC's company story, scientific research, leadership and latest news.

The RoC Story

RoC was founded in Paris in 1957 by Dr. Jean-Charles Lissarrague, a Doctor of Pharmacy.

Its roots go back to the Rogé-Cavaillès pharmacy in Paris, which specialized in dermatology and prepared skincare prescribed by dermatologists. RoC began partnering with dermatologists on research in 1960, creating a relationship between pharmacy, formulation and dermatology that continues today.

RoC Retinol Correxion Deep Wrinkle serum, rich cream and Line Smoothing eye cream
1957Founded in Paris by a Doctor of Pharmacy
Since 1960Partnering with dermatologists on research
250+Clinical efficacy and tolerance studies
Nearly 50Patents awarded on RoC innovations
100%Of RoC formulas are clinically proven

How we develop

L.I.F.E.: how RoC develops skincare with dermatologists

RoC’s partnership with dermatologists still shapes how it develops products. L.I.F.E. brings dermatologists into product development.

L

Learning

Identify the unmet skin need and what consumers are experiencing

I

Ideation

Bring RoC scientists together with dermatologists to define the product opportunity

F

Formulation

Translate those insights into the formula, texture and format

E

Evaluation

Design the clinical protocol, test the finished product and review the results

L.I.F.E. gives dermatologists a role in how the product itself is conceived, formulated and evaluated.

Hands applying RoC serum from a gold pump bottle

How we test

V.I.S.A.: RoC tests the finished product, not just the ingredients inside it

Clinical testing has been part of RoC’s work for decades. RoC’s formulas have been evaluated in more than 250 clinical efficacy and tolerance studies.

The distinction matters because consumers use a finished formula, not an ingredient in isolation. RoC uses V.I.S.A. to assess the product people put on their skin through four complementary forms of evaluation.

V

Visualization

Use high-resolution digital imaging to document visible changes in the skin

I

Instrumental measurements

Objectively measure changes in the skin

S

Scoring

Have clinical experts assess the results

A

Assessment

Understand the consumer’s experience using the product

Together, L.I.F.E. and V.I.S.A. describe two different parts of the development process. L.I.F.E. brings dermatologists into product development. V.I.S.A. defines how RoC evaluates the finished formula.

Dr. Angela Lamb, RoC’s Chief Dermatologist, chairs the Derm Advisory Board, which works with RoC researchers from the first product idea through review of clinical results.

Retinol and innovation

RoC Retinol: first to stabilize retinol in a skincare product, 1995

RoC Retinol Correxion capsule jars with the Pharmacie Française 1957 seal

Retinol is where RoC has done some of its longest-running scientific work.

In 1995, RoC became the first to stabilize retinol in a skincare product. Since then, the company has continued to study not only what retinol can do, but what determines whether it performs well in a finished formula: stability, concentration, ingredient combinations, formulation and consistent use.

7x

RoC’s Patented Clinical Retinol Technology is clinically proven to be 7x more effective than standard retinol* and is used in selected RoC retinol products.

*Based on a clinical study comparing RoC Patented Clinical Retinol with an equal concentration of standard retinol: wrinkle improvement after 12 weeks, 34 subjects.

In 2015, RoC published a one-year clinical study showing that the benefits of its retinol did not plateau after a year of use.

In 2025, RoC completed a study benchmarking the stability of 35 retinoid formulas, adding to its work on one of the central challenges in retinol formulation. The research was presented at the American Academy of Dermatology (AAD) Annual Meeting in March 2026.

What RoC has learned about retinol now informs a wider formulation strategy.

Patents across the RoC portfolio

Over the past five decades, nearly 50 patents have been awarded on RoC innovations. As of 2026, six are active, and five of the six relate to retinol. RoC also has additional patent applications pending across its portfolio.

In January 2026, RoC was granted U.S. Patent 12,521,335 for its stabilized Vitamin C + Peptides combination, used in Revive + Glow Daily Serum and the reformulated Revive + Glow Vitamin C Eye Balm.

Retinol Correxion® Line Smoothing Triple Serum is a patent-pending formula combining hyaluronic acid, micro-encapsulated retinol and PDRN. This (vegan) PDRN is ginseng-derived and inspired by ingredients used in aesthetic procedures. It is formulated to visibly smooth skin.

The same questions RoC has spent decades asking about retinol now apply more broadly: how established skincare ingredients can be combined and stabilized within finished formulas.

Our proposition

RoC brings together clinically proven efficacy, a considered product experience and accessible pricing

RoC’s proposition is that consumers should not have to choose between efficacy, experience and accessibility.

Its products combine clinically proven efficacy with accessible pricing and wide availability across pharmacy, retail and digital channels. At the same time, formulation includes more than the actives inside the product. Texture, sensoriality, packaging and format all affect whether someone wants to use a product consistently.

The product experience is therefore part of the formulation brief. A product must work, but it must also feel good enough and be easy enough to use regularly.

Sticks, roll-ons, capsules and other formats are designed to make application easier and more precise, and to fit effective skincare into a daily routine.

The aim is clinically proven efficacy and an experience people enjoy, at an accessible price.

Across its history, RoC’s signature has evolved from “hypo-allergenic” to “We keep our promises” and, today, “RoC Clinically Proven.”

Two RoC serum capsules held in tweezers RoC Even Tone Dark Spot Roll-On Serum RoC Revive + Glow Brightening Eye Balm with orange slices
Formats Sticks, roll-ons and capsules
Woman applying a RoC stick to her cheekbone

French pharmacy

For RoC, French pharmacy means formulation, tolerance, clinical evidence and results over time

RoC’s French pharmacy heritage is more than a place of origin. It established expectations about what skincare should do.

In the 1960s, Dr. Lissarrague set out “The RoC Concept,” seven principles for hypo-allergenic skincare that were included with every pack. New raw materials and finished products were tested on allergic patients in hospitals under dermatologist supervision.

That history established an emphasis on skin compatibility, evidence and products practical enough to use every day. The same thinking continues in the way RoC develops formulas around a defined skin need, evaluates the finished product and substantiates the claims it makes.

You can see that connection in RoC’s later work on stabilized retinol, clinical testing and products designed to fit easily into regular skincare routines.

In 2024, RoC returned to French pharmacies with a direct presence in France, bringing the brand back into the setting where this way of working began.

Mind the Gap

RoC’s Mind the Gap research finds a nine-year gap between chronological and felt age, reframing what women want from skincare

55Average chronological age
46Average felt age

RoC introduced its brand platform, Look as Young as You Feel, in France in 2024 with RoC 35, a five-product protocol tested across 35 French clinics.

In 2026, RoC’s Mind the Gap study put numbers behind that idea. It surveyed 6,818 women ages 35 and over across 12 countries. Their average chronological age was 55. Their average felt age was 46.

That nine-year difference changes the question skincare is trying to answer. Many women are not simply trying to look younger. They want what they see in the mirror to feel more consistent with how they see themselves.

That is the role of Look as Young as You Feel within the RoC story: it gives the company’s science a more human purpose. RoC’s stated aim is to help skin look younger for longer.

A clinical study of Retinol Correxion Line Smoothing Triple Serum showed a visible 7-year reduction in skin age in 4 weeks†.

†Clinical assessment of crow’s feet and under-eye wrinkles: 29 subjects, total study duration 12 weeks, results after 1 month.

Woman holding a gold RoC serum bottle

The science of aging

RoC’s research draws on the latest science of aging

RoC is broadening its research to how skin itself changes over time and how skincare can help skin look younger for longer.

That work includes questions RoC has been studying for years, now viewed through a longer lens: how established dermatologic ingredients can be improved, how finished products should be clinically tested, how skincare can complement in-office aesthetic treatments and how new technologies and formats can address changing skin needs.

Together, this work allows RoC to study aging from three directions: how skin changes over time, how established skincare ingredients can help the look of skin as it changes and how consumer needs are changing alongside them. That shift is already visible: the Derm Correxion® Firming Serum Stick has become popular with people concerned about the look of skin laxity after significant weight loss, including users of GLP-1 (glucagon-like peptide-1) medicines‡.

‡Consult with your doctor when using skincare combined with GLP-1.

2025

Longevity Council and university research fund

In 2025, the company formed its Longevity Council, a panel of experts in dermatology, aging biology and precision medicine, and established a research fund with a leading U.S. university to study the biology of aging.

March 2026

Studies presented at AAD

At AAD in March 2026, RoC presented its 35-formula retinoid stability study, its ex vivo Retinol Genome Study, an ex vivo Patented Clinical Retinol vs. Retinal explant study and first results from a pilot clinical study of Clinical Retinol in identical twins.

Now recruiting

12-week identical twins study

RoC is now expanding that work with a 12-week U.S. study recruiting at least 30 pairs of female identical twins. The study will pair clinical skin assessments with biometric data captured through Oura Rings to examine how Clinical Retinol and lifestyle relate to visible skin aging and skin longevity.

2026

A Chief Dermatologist to connect the work

In 2026, RoC appointed Dr. Angela Lamb as Chief Dermatologist. She chairs both the Derm Advisory Board and the Longevity Council, connecting the company’s product-development work with its broader research into aging.

Dr. Angela LambDr. Angela Lamb
Chief Dermatologist

Nearly 70 years

Nearly 70 years of practical advances in skincare

RoC’s history matters because the same pattern appears repeatedly: identify a specific skincare problem, develop a practical solution and test whether it works.

More recently, the same problem-solving approach has produced RoC’s first retinol capsules, first retinol firming stick, first lip volumizing treatment and first at-home peel pads. The products change. The development pattern remains consistent: understand the need, formulate around it, find a practical way for people to use the product and test the result.

1957

The company became France’s first hypo-allergenic skincare brand and launched “Écran total RoC,” the first sunscreen combining chemical and physical protectants for both UVA and UVB coverage.

1984

RoC developed and patented a method for verifying that formulas were non-comedogenic, making it one of the first non-comedogenic brands.

1987

Myosphère became the first liposomal skincare emulsion sold in pharmacies.

1995

RoC became the first to stabilize retinol in a skincare product.

2020

RoC launched its first retinol capsules, Retinol Correxion Capsules.

2024

RoC launched its first Retinol Firming Stick, the Derm Correxion Firming Serum Stick.

Leadership

Executive Leadership Team

Fernando Acosta

Fernando Acosta

Chief Executive Officer

Fernando Acosta is Chief Executive Officer of RoC Skincare. He joined RoC in 2019 as its first employee following the brand’s carve-out from Johnson & Johnson and has built it into a standalone global company. Fernando previously spent 20 years at Unilever, including as Dove Global Brand President, and later served at Avon Products as President for Latin America and then Chief Marketing & Social Selling Officer.

Jay Brandimarte

Jay Brandimarte

Chief Financial Officer

Jay Brandimarte is Chief Financial Officer of RoC Skincare and leads the company’s finance organization, overseeing financial planning and analysis, forecasting, accounting and treasury across its global operations. Before joining RoC in 2019, he served as CFO of two other private equity-backed beauty companies and spent seven years at Avon Products, most recently as CFO of Latin America.

Brian King

Brian King

Chief Customer Officer

Brian King is Chief Customer Officer of RoC Skincare. His remit spans digital and brick-and-mortar sales in North America, the U.K. and Australia, as well as RoC’s Amazon business globally. Before joining RoC in 2020, he spent 21 years at Colgate-Palmolive, most recently as Vice President of U.S. Customer Development, where he led Colgate’s entire U.S. sales force.

Marie-Caroline Renault

Marie-Caroline Renault

Chief Marketing Officer

Marie-Caroline Renault was appointed Chief Marketing Officer of RoC Skincare in 2026 and leads the brand’s global marketing strategy. She joined the company in 2024 as Vice President, Innovation, and has led the renewal of the brand’s design and the launch of its brand platform, “Look as Young as You Feel.” Marie-Caroline has more than 25 years of experience in beauty, including seven years as Brand Vice President at Laboratoires Filorga and nearly a decade at L’Oréal.

Richard P. Davies

Richard P. Davies

General Counsel & Chief Administrative Officer

Richard Davies is General Counsel & Chief Administrative Officer of RoC Skincare and leads its Legal, Compliance, Human Resources and Administration functions. He joined the company in 2024 from Natura &Co, where he was Group Vice President, Ethics & Compliance, after roles leading corporate and securities, mergers and acquisitions, restructuring, and compliance at Avon Products. Richard previously practiced as a corporate transactions and securities lawyer at two New York City law firms.

Art Pellegrino

Art Pellegrino

Chief Scientific Officer

Art Pellegrino is Chief Scientific Officer of RoC Skincare and leads R&D, product development, clinical research and new technology. He joined RoC as Head of R&D in 2019 and is best known for his work in retinol science, developing a commercial process for stabilizing retinol. Art spent over two decades at Johnson & Johnson, rising to Senior Director of R&D, and is a named inventor on multiple skincare patents.

FangChi Wu

FangChi Wu

Senior Vice President, Marketing, Anglo Markets

FangChi Wu is Senior Vice President of Marketing at RoC Skincare and leads marketing across the U.S., Canada, the U.K. and Australia. She joined RoC in 2024 as Vice President of Strategy & Execution, where she led initiatives to accelerate international expansion in Europe and spearheaded RoC’s AI strategy. FangChi previously spent 15 years at P&G, McKinsey & Company and The Estée Lauder Companies.

Iris Lo

Iris Lo

Senior Vice President, Supply Chain

Iris Lo is Senior Vice President of Supply Chain at RoC Skincare and leads end-to-end supply chain strategy and execution. Before joining RoC in 2019, she spent eight years at Elizabeth Arden, where she helped transform its supply chain from a tolling to a turnkey manufacturing model and integrate its supply teams with Revlon’s. Iris began her career at Johnson & Johnson.

Julien Pasquini

Julien Pasquini

General Manager, RoC Skincare France

Julien Pasquini is General Manager of RoC Skincare France. He joined the company in 2024 to lead RoC’s return to its historic French market and has strengthened RoC’s presence across the French pharmacy channel. Before joining RoC, he was Commercial Director France at Arkopharma for nearly eight years and spent more than 16 years at Sanofi.

Roberto De Santis

Roberto De Santis

General Manager, RoC Skincare Southern Europe & Distributor Markets

Roberto De Santis is General Manager for Southern Europe and Distributor Markets at RoC Skincare. Since 2024, he has led the company’s regional hub in Milan, returned RoC to growth in the Italian pharmacy channel and led its simultaneous launch in five Eastern European markets. Before joining RoC, he was General Manager of Filorga Italia, part of Colgate-Palmolive’s Skin Health division.

David Fernandez-Gomez

David Fernandez-Gomez

General Manager, RoC Skincare Spain and Portugal

David Fernandez-Gomez is General Manager of RoC Skincare Spain and Portugal. He joined RoC in 2025 and leads the business with full P&L responsibility. Before joining RoC, he spent nearly nine years as General Manager Spain and Portugal at Teoxane, where he built the Iberian subsidiary from the ground up.

RoC Today

RoC Skincare milestones, 1957 to 2026

Key moments in RoC’s history, from its founding in Paris in 1957 to its latest research and product launches.

Swipe or use the arrows
1957

RoC is founded in Paris

Cosmétique Médicale S.A. is founded by Dr. Jean-Charles Lissarrague, a Doctor of Pharmacy. RoC becomes France’s first hypo-allergenic skincare brand. That year, RoC also launches “Écran total RoC,” the first sunscreen combining chemical and physical protectants for both UVA and UVB coverage.

1958

Dr. Jean-Charles Lissarrague publishes a medical paper on lipstick allergies

Published in the Bulletin de la Société de Dermo-Pharmacie.

1960

RoC begins partnering with dermatologists on research

Today, L.I.F.E. (Learning, Ideation, Formulation, Evaluation) brings dermatologists into product development.

1983

RoC S.A. obtains Pharmaceutical Laboratory status

The company, founded as Cosmétique Médicale S.A., became RoC-Cosmétique Médicale S.A. in 1965 and RoC S.A. in 1968.

1984

RoC patents a method for verifying formulas as non-comedogenic

The work makes RoC one of the first non-comedogenic brands.

1987

RoC launches Myosphère

Myosphère is the first liposomal skincare emulsion sold in pharmacies.

1989

RoC ends animal testing

RoC ends animal testing in August 1989. Today, RoC is listed by PETA.

1993

RoC forms a U.S. joint venture with Dermik Laboratories

A joint venture with Dermik Laboratories, Inc. markets and distributes RoC products in the U.S.

1995

Retinol Actif Pur launches

RoC becomes the first to stabilize retinol in a skincare product.

1999

Retinol Line Smoothing Eye Cream launches

The launch expands RoC’s retinol portfolio.

2001

The “10 Years Back” claim is clinically validated

2003

The “10 Years Back” claim launches with Retin-OX

2015

RoC publishes a one-year retinol clinical study

The study shows that benefits do not plateau after one year of use.

2020

RoC launches its first retinol capsules

Retinol Correxion Capsules bring RoC’s retinol into capsule format for the first time.

2022

Derm Correxion launches

The line is developed with dermatologists and inspired by in-office procedures.

Its hero product, Fill + Treat, is a filler-inspired anti-wrinkle serum featuring a patent-pending retinol complex.

2023

RoC launches Revive + Glow Vitamin C Eye Balm

The product is RoC’s first eye balm.

2024

RoC launches the Derm Correxion Firming Serum Stick

RoC’s first Retinol Firming Stick becomes the #1 new serum launch in the U.S. in 2024.

Nielsen xAOC, serum segment, 26 weeks ending December 28, 2024.

2024

RoC returns to France

RoC Skincare France opens in Paris and RoC relaunches in French pharmacies.

2024

RoC Retinol Genome Study is first presented in Paris

The ex vivo study is first presented at the RoC France launch PR event in September 2024.

It is later presented at the American Academy of Dermatology (AAD) Annual Meeting in March 2026.

2024

RoC 35 launches with Look as Young as You Feel

RoC introduces its new brand platform, Look as Young as You Feel, with RoC 35, its five-product protocol tested across 35 French clinics.

2025

Derm Correxion Lip Volumizer launches

RoC introduces its first Lip Volumizing Treatment, extending the Derm Correxion line into a topical lip treatment inspired by in-office procedures. It becomes the #1 new U.S. skincare launch in Q4 2025‖. It has received six beauty awards since its launch.

‖Nielsen xAOC, facial skincare excluding cleansers and acne, 13 weeks ending December 27, 2025.

2025

RoC completes a retinol stability study

RoC completes a study benchmarking the stability of 35 retinoid formulas.

Results are later presented at AAD in March 2026.

2025

RoC forms its Longevity Council and establishes a research fund with a leading U.S. university to study the biology of aging

The initiatives extend RoC’s work beyond traditional anti-aging claims into research on aging and skin over time.

2026

U.S. Patent 12,521,335 is granted

The U.S. patent covers RoC’s stabilized Vitamin C + Peptides combination, used in Revive + Glow Daily Serum and the reformulated Revive + Glow Vitamin C Eye Balm.

2026

Dr. Angela Lamb becomes RoC’s Chief Dermatologist

She chairs both the Derm Advisory Board and the Longevity Council.

2026

RoC presents new retinol science at AAD

The company presents its ex vivo Retinol Genome Study and an ex vivo Patented Clinical Retinol vs. Retinal explant study.

RoC also presents first results from a pilot clinical study of Clinical Retinol in identical twins.

2026

RoC expands its Clinical Retinol research in identical twins

RoC begins recruiting at least 30 pairs of female identical twins in the U.S. for an expanded 12-week clinical study.

The study combines RoC’s standard clinical skin measures with biometric data from Oura Ring to examine how Clinical Retinol and lifestyle relate to visible skin aging and skin longevity.

Clinical assessments include expert grading, digital photography, corneometer readings and subject self-assessment. Oura Ring data include measures such as sleep, stress, heart rate, heart rate variability and temperature trends.

Results are expected in mid-2027.

2026

RoC launches Retinol Correxion Line Smoothing Triple Serum

A clinical study shows a visible 7-year reduction in skin age in 4 weeks†.

†Clinical assessment of crow’s feet and under-eye wrinkles: 29 subjects, total study duration 12 weeks, results after 1 month.

Triple Serum is a patent-pending formula combining hyaluronic acid, micro-encapsulated retinol and PDRN. This (vegan) PDRN is ginseng-derived and inspired by ingredients used in aesthetic procedures. It is formulated to visibly smooth skin.

2026

RoC launches Retinol Correxion Line Smoothing 2-Step Peel Pads

The Peel Pads bring Patented Clinical Retinol into an at-home format inspired by professional peels.

2026

RoC’s Mind the Gap study quantifies the felt-age gap

The study surveys 6,818 women ages 35 and over across 12 countries.

Women report feeling nine years younger than their chronological age on average, with an average felt age of 46 compared with an average chronological age of 55.

1957 to 2026

Corporate FAQ

About RoC

What does RoC stand for?

The RoC name comes from the Rogé-Cavaillès pharmacy in Paris: “Ro” from Rogé and “C” from Cavaillès. The name was registered in 1955. The pharmacy, founded a century earlier in 1855, specialized in dermatology and prepared skincare prescribed by dermatologists.

Who founded RoC and when?

RoC was founded in Paris in 1957 by Dr. Jean-Charles Lissarrague, a Doctor of Pharmacy. He acquired the Rogé-Cavaillès pharmacy in 1944 and founded Cosmétique Médicale S.A. in 1957. That year, RoC became France’s first hypo-allergenic skincare brand.

What is RoC known for?

RoC is known for clinically proven efficacy, retinol expertise, French pharmacy heritage and a longstanding relationship with dermatologists.

The company was founded in Paris in 1957 by a Doctor of Pharmacy and has partnered with dermatologists on research since 1960.

Today, selected products are developed with dermatologists through a process that can include input from the initial skin need through formulation, clinical protocol design and review of results.

In 1995, RoC became the first to stabilize retinol in a skincare product and has continued its work on retinol for more than three decades.

RoC’s formulas have been evaluated in more than 250 clinical efficacy and tolerance studies.

RoC is #1 in retinol in the U.S.** and #1 in eye care in the U.S.††.

RoC has won beauty awards every year since 2006, nearly 200 in all. That includes more than 30 since 2024, more than 100 for Retinol Correxion products and nearly 50 for its eye care products. Retinol Correxion Deep Wrinkle Night Cream, RoC’s most awarded product, has received more than 25.

**Nielsen xAOC, Retinol segment, 52 weeks ending May 16, 2026.

††Nielsen xAOC, eye segment, 52 weeks ending August 8, 2026.

What is RoC’s French pharmacy heritage?

RoC was born in French pharmacy.

The Rogé-Cavaillès pharmacy in Paris, founded in 1855, specialized in dermatology and prepared bespoke skincare prescribed by dermatologists. Dr. Jean-Charles Lissarrague, a Doctor of Pharmacy, acquired the pharmacy in 1944.

The RoC name, “Ro” from Rogé and “C” from Cavaillès, was registered in 1955. Cosmétique Médicale S.A. was founded in Paris in 1957.

The earliest RoC products were sold as “adallergique,” a term coined by Dr. Lissarrague. In the 1960s, he also set out “The RoC Concept,” seven principles for hypo-allergenic skincare.

RoC began partnering with dermatologists on research in 1960. Today, that relationship continues through L.I.F.E. (Learning, Ideation, Formulation, Evaluation), which brings dermatologists into product development, and V.I.S.A. (Visualization, Instrumental measurements, Scoring, Assessment), which RoC uses to evaluate finished formulas.

For RoC, French pharmacy means formulation, tolerance, clinical evidence and results over time.

Science and people

How does RoC develop and test its skincare?

RoC brings dermatologists into product development through L.I.F.E. (Learning, Ideation, Formulation, Evaluation) and evaluates finished formulas through V.I.S.A. (Visualization, Instrumental measurements, Scoring, Assessment).

L.I.F.E.

  • Learning: Identify the unmet skin need and what consumers are experiencing
  • Ideation: Bring RoC scientists together with dermatologists to define the product opportunity
  • Formulation: Translate those insights into the formula, texture and format
  • Evaluation: Design the clinical protocol, test the finished product and review the results

V.I.S.A.

  • Visualization: Use high-resolution digital imaging to document visible changes in the skin
  • Instrumental measurements: Objectively measure changes in the skin
  • Scoring: Have clinical experts assess the results
  • Assessment: Understand the consumer’s experience using the product

L.I.F.E. brings dermatologists into product development. V.I.S.A. describes how RoC assesses the finished formula.

RoC’s formulas have been evaluated in more than 250 clinical efficacy and tolerance studies.

How does RoC work with dermatologists?

RoC has partnered with dermatologists on research since 1960.

Today, L.I.F.E. brings dermatologists into product development.

Dr. Angela Lamb, RoC’s Chief Dermatologist, chairs both the Derm Advisory Board and the Longevity Council.

RoC presented research at the American Academy of Dermatology (AAD) Annual Meeting in March 2026. It has appeared at IMCAS (International Master Course on Aging Science) in Paris since 2025 and, in 2026, attended the European Academy of Dermatology and Venereology (EADV) Congress in Vienna.

RoC is one of the Top 3 dermatologist-recommended anti-aging skincare brands in the U.S.§

§IQVIA ProVoice Survey, Oct 2026.

Who is Dr. Angela Lamb?

Dr. Angela Lamb became RoC’s Chief Dermatologist in 2026. She chairs both the Derm Advisory Board and the Longevity Council, connecting RoC’s product development with its research into aging.

Retinol

What makes RoC’s retinol different?

RoC has spent more than three decades studying how retinol performs in a finished skincare formula.

In 1995, RoC became the first to stabilize retinol in a skincare product.

Its Patented Clinical Retinol Technology is clinically proven to be 7x more effective than standard retinol* and is used in selected RoC retinol products.

As of 2026, five of RoC’s six active patents relate to retinol.

In 2015, RoC published a one-year clinical study showing that the benefits of its retinol did not plateau after a year of use.

In 2025, it completed a study benchmarking the stability of 35 retinoid formulas. The research was presented at AAD in March 2026.

At AAD, RoC also presented first results from a pilot clinical study of Clinical Retinol in identical twins. RoC is now expanding that work through a 12-week study involving at least 30 pairs of female identical twins in the U.S.

*Based on a clinical study comparing RoC Patented Clinical Retinol with an equal concentration of standard retinol: wrinkle improvement after 12 weeks, 34 subjects.

What is Patented Clinical Retinol?

RoC’s Patented Clinical Retinol Technology is clinically proven to be 7x more effective than standard retinol*.

It builds on more than three decades of retinol research since RoC became the first to stabilize retinol in a skincare product in 1995.

Patented Clinical Retinol is used in selected RoC products.

*Based on a clinical study comparing RoC Patented Clinical Retinol with an equal concentration of standard retinol: wrinkle improvement after 12 weeks, 34 subjects.

What patents does RoC hold?

Nearly 50 patents have been awarded on RoC innovations over the past five decades. As of 2026, six are active, and five of the six relate to retinol. RoC also has additional patent applications pending across its portfolio. In January 2026, RoC was granted U.S. Patent 12,521,335 for its stabilized Vitamin C + Peptides combination, used in Revive + Glow Daily Serum and the reformulated Revive + Glow Vitamin C Eye Balm.

Research and aging

What does Look as Young as You Feel mean?

Look as Young as You Feel is RoC’s brand platform. It reflects the difference between chronological age and the age women say they feel.

RoC introduced the idea in France in 2024 with RoC 35, its five-product protocol tested across 35 French clinics.

Its 2026 Mind the Gap research surveyed 6,818 women across 12 countries and found an average nine-year difference between chronological and felt age.

For RoC, that reframes what women want from skincare. The aim is not simply to make women look younger, but to help their skin look more consistent with how they feel.

A clinical study of Retinol Correxion Line Smoothing Triple Serum showed a visible 7-year reduction in skin age in 4 weeks†.

†Clinical assessment of crow’s feet and under-eye wrinkles: 29 subjects, total study duration 12 weeks, results after 1 month.

What is the Mind the Gap study?

Mind the Gap is RoC’s 2026 survey of 6,818 women ages 35 and over across 12 countries. On average, the women were 55 but felt 46, a nine-year gap.

What is RoC 35?

RoC 35 is a five-product protocol tested across 35 French clinics. It launched in France in 2024 with Look as Young as You Feel.

What is RoC doing in healthy aging and longevity?

RoC’s research draws on the latest science of aging to study how skincare can help skin look younger for longer.

In 2025, the company formed its Longevity Council and established a research fund with a leading U.S. university to study the biology of aging.

Its work now looks at aging from three related directions: how skin changes over time, how established skincare ingredients can help the look of skin as it changes and how consumer needs are changing alongside them.

In 2026, RoC presented first results from a pilot clinical study of Clinical Retinol in identical twins and began expanding that work through a 12-week study involving at least 30 pairs of female identical twins in the U.S.

The expanded study combines clinical skin assessments with biometric data from Oura Ring to examine how Clinical Retinol and lifestyle relate to visible skin aging and skin longevity.

RoC’s Mind the Gap study, a 2026 survey of 6,818 women ages 35 and over across 12 countries, found that they felt nine years younger than their chronological age on average.

A clinical study of Retinol Correxion Line Smoothing Triple Serum showed a visible 7-year reduction in skin age in 4 weeks†.

†Clinical assessment of crow’s feet and under-eye wrinkles: 29 subjects, total study duration 12 weeks, results after 1 month.

What is the RoC identical twins study?

RoC is studying Clinical Retinol in identical twins. First results from a pilot study were presented at AAD in March 2026. An expanded 12-week U.S. study is now recruiting at least 30 pairs of female identical twins, pairing clinical skin assessments with Oura Ring data on sleep, stress, heart rate, heart rate variability and temperature trends. Results are expected in mid-2027. Because identical twins share the same genetic blueprint, differences that emerge over the course of the study are less likely to be explained by genetics. In the pilot study, one twin in each pair used the full formula and the other a placebo.

Why is the Derm Correxion Firming Serum Stick popular with GLP-1 users?

The Firming Stick has become popular with people concerned about the look of skin laxity after significant weight loss, including GLP-1 users‡. RoC products are cosmetics and are not intended to treat the effects of any medicine.

‡Consult with your doctor when using skincare combined with GLP-1.

What happens to skin during significant weight loss?

When people lose a lot of weight, especially quickly, skin can look looser, most often on the face, neck and jawline. Skincare can’t replace lost volume, but it can help the look of skin as it changes.

Which RoC products are in the GLP-1 Skin Support Routine?

RoC’s GLP-1 Skin Support Routine was developed with Dr. Angela Lamb, RoC’s Chief Dermatologist. It has five steps: the Derm Correxion Dual Eye Cream, the Derm Correxion Fill + Treat Serum, the Derm Correxion Firming Serum Stick, the Multi Correxion® Firm + Lift Anti-Sagging Firming Cream and the Derm Correxion Lip Volumizer‡.

‡Consult with your doctor when using skincare combined with GLP-1.

Can I use RoC products while taking a GLP-1 medicine?

RoC products are cosmetics for the look of skin and are not a treatment for the side effects of any medicine. If you have questions about your medicine or your skin, talk to your doctor.

Products and approach

What is RoC’s approach to skincare?

RoC brings together clinically proven efficacy, a considered product experience and accessible pricing.

The company treats product experience as part of product performance. Texture, sensoriality and format affect whether people want to use skincare consistently, while accessible pricing and broad availability make those products easier to incorporate into everyday routines.

Formats including sticks, roll-ons and capsules are designed for easier, more precise application.

The proposition is straightforward: skincare should work, feel good to use and be accessible enough to become part of everyday life.

Why does RoC make products in sticks, roll-ons and capsules?

These formats are designed to make application easier and more precise, and to fit effective skincare into a daily routine. RoC’s format firsts include retinol capsules (2020), a retinol firming stick (2024), a lip volumizing treatment (2025) and at-home peel pads (2026).

What is Retinol Correxion Line Smoothing Triple Serum?

Triple Serum is a patent-pending formula combining hyaluronic acid, micro-encapsulated retinol and PDRN. This (vegan) PDRN is ginseng-derived and inspired by ingredients used in aesthetic procedures. It is formulated to visibly smooth skin. A clinical study showed a visible 7-year reduction in skin age in 4 weeks†.

†Clinical assessment of crow’s feet and under-eye wrinkles: 29 subjects, total study duration 12 weeks, results after 1 month.

News & Perspectives

Latest from RoC

View all
News

Women feel nine years younger than their age, RoC study finds

Woman holding a gold RoC serum bottle

RoC’s 12-country Mind the Gap study finds women 35 and over see aging through the lens of health and longevity, while an industry built on “anti-aging” is only now catching up

· RoC Skincare Communications Team
Research

Mind the Gap: what 6,818 women told RoC about aging

Woman applying a RoC stick to her cheekbone

Selected findings from RoC’s 12-country Mind the Gap study of 6,818 women.

· RoC Skincare Communications Team
Perspectives

What French pharmacy brings to modern skincare

Woman with a swatch of RoC cream on her cheek

In a skincare market where K-beauty is often associated with discovery and new formats, RoC’s French pharmacy heritage offers a different proposition: formulation, tolerance, clinical evidence and results over time, alongside new formats of its own.

· RoC Skincare Communications Team